Fig. 3From: Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchronous lung adenocarcinomaTherapy response after 4 cycles pembrolizumab/carboplatin/pemetrexed. Maximal intensity projection (MIP) of [18F]FDG PET/CT A before treatment start, B after 4 cycles immuno-chemotherapy. In A, B the area of the supraglottic laryngeal cancer is indicated by a green arrow. C Microlaryngoscopic view of the laryngeal cancer before treatment start during diagnostic panendoskopy. D Microlaryngoscopic view of the same area after 4 cycles immuno-chemotherapy during a control panendoscopyBack to article page